Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID
Public ClinicalTrials.gov record NCT05638620. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2 (PASC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to gather data and assess changes in patient-reported outcomes with the stellate ganglion blocks as treatment for their sympathetically-mediated long COVID symptoms.
Study identification
- NCT ID
- NCT05638620
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 20 participants
Conditions and interventions
Conditions
- Post Acute COVID-19 Syndrome
- Long COVID
- Long Covid19
- COVID-19 Recurrent
- Post-Acute COVID-19
- Post-Acute COVID-19 Infection
- SARS-CoV2 Infection
- Post Acute Sequelae of COVID-19
- Dysautonomia
- Dysautonomia Like Disorder
- Dysautonomia Orthostatic Hypotension Syndrome
- Post COVID-19 Condition
- Post-COVID Syndrome
- Post COVID-19 Condition, Unspecified
- Post-COVID-19 Syndrome
Eligibility (public fields only)
- Age range
- 18 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2, 2023
- Primary completion
- Jun 14, 2023
- Completion
- Dec 29, 2023
- Last update posted
- Mar 12, 2025
2023
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hudson Medical | New York | New York | 10014 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Long COVID trials
Other public records listing Long COVID. Sorted by last update posted; newest first. Not a recommendation.
- NCT06847191: NE3107 in Adults With Neurological Symptoms of Long COVID Active, not recruiting
- NCT07770022: Validation of Biomarkers for Long COVID in the LIINC Viral Immunopathogenesis and Persistence Repeat Donor Cohort (VIPER) Recruiting
- NCT06920628: PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Recruiting
- NCT06585254: tVNS in Long COVID-19 Active, not recruiting
- NCT05373043: Long-term COVID and Rehabilitation Recruiting
- NCT06928116: Heat thErapy And mobiLity in COVID-19 Survivors Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05638620, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 12, 2025 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05638620 live on ClinicalTrials.gov.